Literature DB >> 24900416

GPR119 Modulators for the Treatment of Diabetes, Obesity, and Related Diseases: Patent Highlight.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2012        PMID： 24900416      PMCID： PMC4025843          DOI： 10.1021/ml300296q

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Diabetes area participation analysis: a review of companies and targets described in the 2008 - 2010 patent literature.

Authors:  Philip A Carpino; Bryan Goodwin
Journal:  Expert Opin Ther Pat       Date:  2010-12       Impact factor: 6.674

Review 2.  GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity.

Authors:  H A Overton; M C T Fyfe; C Reynet
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 3.  GPR119 as a fat sensor.

Authors:  Harald S Hansen; Mette M Rosenkilde; Jens J Holst; Thue W Schwartz
Journal:  Trends Pharmacol Sci       Date:  2012-05-02       Impact factor: 14.819
  3 in total
  1 in total

Review 1.  Metabolic Functions of G Protein-Coupled Receptors and β-Arrestin-Mediated Signaling Pathways in the Pathophysiology of Type 2 Diabetes and Obesity.

Authors:  Camila Oliveira de Souza; Xuenan Sun; Dayoung Oh
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-23       Impact factor: 5.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.